Pregnancy as a critical window for blood pressure regulation in mother and child: programming and reprogramming

Acta Physiologica

Volumn 219, Issue 1, 2017, Pages 241-259

  Paauw, N D ^a   van Rijn, B B ^a,b   Lely, A T ^a   Joles, J A ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

hypertension; intrauterine growth restriction; long term blood pressure regulation; pre eclampsia; programming; reprogramming

Indexed keywords

ANGIOGENIC FACTOR; ANGIOTENSIN II; SODIUM; VASODILATOR AGENT;

ADRENERGIC SYSTEM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CELL COUNT; CHILD; EPIGENETICS; FEMALE; FETUS BLOOD; FOLLOW UP; HUMAN; MATERNAL HYPERTENSION; MOTHER; NEPHRON; NONHUMAN; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; POSTNATAL CARE; PRIORITY JOURNAL; PROGENY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; BLOOD PRESSURE; FETUS DEVELOPMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

BLOOD PRESSURE; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MOTHERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84971476089     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12702     Document Type: Review

References (187)

1. Adams, T., Yeh, C., Bennett-Kunzier, N. & Kinzler, W.L. 2014. Long-term maternal morbidity and mortality associated with ischemic placental disease. Semin Perinatol 38, 146–150.
2. Agarwal, I. & Karumanchi, S.A. 2011. Preeclampsia and the anti-angiogenic state. Pregnancy Hypertension 1, 17–21.
3. Alexander, B.T. 2003. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension 41, 457–462.
4. Alwasel, S.H. & Ashton, N. 2009. “Prenatal programming of renal sodium handling in the rat”. Clin Sci 117, 75–84.
5. Alwasel, S.H., Barker, D.J. & Ashton, N. 2012. Prenatal programming of renal salt wasting resets postnatal salt appetite, which drives food intake in the rat. Clin Sci, 122, 281–288.
6. Bakker, W.W., Henning, R.H., van Son, W.J., van Pampus, M.G., Aarnoudse, J.G., Niezen-Koning, K.E., Borghuis, T., Jongman, R.M., van Goor, H., Poelstra, K., Navis, G. & Faas, M.M. 2009. Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro. Hypertension 53, 959–964.
7. Barker, D.J. & Osmond, C. 1988. Low birth weight and hypertension. BMJ 297, 134–135.
8. Barker, D.J., Osmond, C., Golding, J., Kuh, D. & Wadsworth, M.E. 1989. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298, 564–567.
9. Bellamy, L., Casas, J.P., Hingorani, A.D. & Williams, D.J. 2007. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335, 974.
10. Berends, A.L., de Groot, C.J., Sijbrands, E.J., Sie, M.P., Benneheij, S.H., Pal, R., Heydanus, R., Oostra, B.A., van Duijn, C.M. & Steegers, E.A. 2008. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 51, 1034–1041.
11. Berks, D., Steegers, E.A., Molas, M. & Visser, W. 2009. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 114, 1307–1314.
12. de Boer, M.P., Ijzerman, R.G., de Jongh, R.T., Eringa, E.C., Stehouwer, C.D., Smulders, Y.M. & Serne, E.H. 2008. Birth weight relates to salt sensitivity of blood pressure in healthy adults. Hypertension 51, 928–932.
13. Bogdarina, I., Haase, A., Langley-Evans, S. & Clark, A.J. 2010. Glucocorticoid effects on the programming of AT1b angiotensin receptor gene methylation and expression in the rat. PLoS One 5, e9237.
14. Boguszewski, M.C., Johannsson, G., Fortes, L.C. & Sverrisdottir, Y.B. 2004. Low birth size and final height predict high sympathetic nerve activity in adulthood. J Hypertens 22, 1157–1163.
15. Bramham, K., Parnell, B., Nelson-Piercy, C., Seed, P.T., Poston, L. & Chappell, L.C. 2014. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ 348, g2301.
16. Brown, M.C., Best, K.E., Pearce, M.S., Waugh, J., Robson, S.C. & Bell, R. 2013. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 28, 1–19.
17. Buhl, K.B., Friis, U.G., Svenningsen, P., Gulaveerasingam, A., Ovesen, P., Frederiksen-Moller, B., Jespersen, B., Bistrup, C. & Jensen, B.L. 2012. Urinary plasmin activates collecting duct ENaC current in preeclampsia. Hypertension 60, 1346–1351.
18. Byers, B.D., Betancourt, A., Lu, F., Hankins, G.D., Longo, M., Saade, G.R. & Bytautiene, E. 2009. The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model. Am J Obstet Gynecol 200, 432.e1–432.e7.
19. Bytautiene, E., Lu, F., Tamayo, E.H., Hankins, G.D., Longo, M., Kublickiene, K. & Saade, G.R. 2010. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circulat Physiol 298, H189–H193.
20. Bytautiene, E., Bulayeva, N., Bhat, G., Li, L., Rosenblatt, K.P. & Saade, G.R. 2013. Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice. Am J Obstet Gynecol 208, 388.e1–388.e10.
21. Catov, J.M., Dodge, R., Yamal, J.M., Roberts, J.M., Piller, L.B. & Ness, R.B. 2011. Prior preterm or small-for-gestational-age birth related to maternal metabolic syndrome. Obstet Gynecol 117, 225–232.
22. Chaddha, V., Viero, S., Huppertz, B. & Kingdom, J. 2004. Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med 9, 357–369.
23. Chambers, J.C., Fusi, L., Malik, I.S., Haskard, D.O., De Swiet, M. & Kooner, J.S. 2001. Association of maternal endothelial dysfunction with preeclampsia. JAMA 285, 1607–1612.
24. Chappell, L.C., Enye, S., Seed, P., Briley, A.L., Poston, L. & Shennan, A.H. 2008. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 51, 1002–1009.
25. Chen, X. & Wang, Y. 2008. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 117, 3171–3180.
26. Coresh, J., Selvin, E., Stevens, L.A., Manzi, J., Kusek, J.W., Eggers, P., Van Lente, F. & Levey, A.S. 2007. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038–2047.
27. Courtar, D.A., Spaanderman, M.E., Aardenburg, R., Janssen, B.J. & Peeters, L.L. 2006. Low plasma volume coincides with sympathetic hyperactivity and reduced baroreflex sensitivity in formerly preeclamptic patients. J Soc Gynecol Investig 13, 48–52.
28. Craici, I., Wagner, S. & Garovic, V.D. 2008. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2, 249–259.
29. Crispi, F., Bijnens, B., Figueras, F., Bartrons, J., Eixarch, E., Le Noble, F., Ahmed, A. & Gratacos, E. 2010. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 121, 2427–2436.
30. von Dadelszen, P., Dwinnell, S., Magee, L.A., Carleton, B.C., Gruslin, A., Lee, B., Lim, K.I., Liston, R.M., Miller, S.P., Rurak, D., Sherlock, R.L., Skoll, M.A., Wareing, M.M., Baker, P.N. & Research into Advanced Fetal Diagnosis and Therapy (RAFT) Group 2011. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 118, 624–628.
31. Davis, E.F., Lazdam, M., Lewandowski, A.J., Worton, S.A., Kelly, B., Kenworthy, Y., Adwani, S., Wilkinson, A.R., McCormick, K., Sargent, I., Redman, C. & Leeson, P. 2012. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 129, e1552–e1561.
32. Demicheva, E. & Crispi, F. 2014. Long-term follow-up of intrauterine growth restriction: cardiovascular disorders. Fetal Diagn Ther 36, 143–153.
33. Dempsey, J.C., Williams, M.A., Luthy, D.A., Emanuel, I. & Shy, K. 2003. Weight at birth and subsequent risk of preeclampsia as an adult. Am J Obstet Gynecol 189, 494–500.
34. Dharmashankar, K. & Widlansky, M.E. 2010. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 12, 448–455.
35. Dilworth, M.R., Andersson, I., Renshall, L.J., Cowley, E., Baker, P., Greenwood, S., Sibley, C.P. & Wareing, M. 2013. Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype. PLoS One 8, e77748.
36. Drost, J.T., Arpaci, G., Ottervanger, J.P., de Boer, M.J., van Eyck, J., van der Schouw, Y.T. & Maas, A.H. 2012. Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM). Eur J Prev Cardiol 19, 1138–1144.
37. DuBois, B.N., Pearson, J., Mahmood, T., Nguyen, D., Thornburg, K. & Cherala, G. 2014. Perinatal growth restriction decreases diuretic action of furosemide in adult rats. Eur J Pharmacol 728, 39–47.
38. Dutch Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders. 2014. Cardiovascular Risk Management after Reproductive Disorders. Available: http://nvog-documenten.nl/uploaded/docs/richtlijn%20cardiovasculair%20risicomanagement%20na%20reproductieve%20aandoeningen%20dec%202014%20(Projectplace_11451).pdf.
39. Ehrenthal, D.B., Goldstein, N.D., Wu, P., Rogers, S., Townsend, R.R. & Edwards, D.G. 2014. Arterial stiffness and wave reflection 1 year after a pregnancy complicated by hypertension. J Clin Hypertens 16, 695–699.
40. Elvan-Taspinar, A., Bots, M.L., Franx, A., Bruinse, H.W. & Engelbert, R.H. 2005. Stiffness of the arterial wall, joints and skin in women with a history of pre-eclampsia. J Hypertens 23, 147–151.
41. Erkadius, E., Morgan, T.O. & Di Nicolantonio, R. 1996. Full expression of the exaggerated salt appetite of the spontaneously hypertensive rat requires a prenatal factor. Clin Exp Pharmacol Physiol 23, 619–620.
42. Faas, M.M., Schuiling, G.A., Baller, J.F., Visscher, C.A. & Bakker, W.W. 1994. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171, 158–164.
43. Finer, L.B. & Zolna, M.R. 2014. Shifts in intended and unintended pregnancies in the United States, 2001-2008. Am J Public Health 104(Suppl 1), S43–S48.
44. Fischer, M., Baessler, A. & Schunkert, H. 2002. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53, 672–677.
45. Fischer, M.J., Lehnerz, S.D., Hebert, J.R. & Parikh, C.R. 2004. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis 43, 415–423.
46. Fraser, A., Nelson, S.M., Macdonald-Wallis, C., Sattar, N. & Lawlor, D.A. 2013. Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension 62, 614–620.
47. Gallery, E.D. & Brown, M.A. 1987. Control of sodium excretion in human pregnancy. Am J Kidney Dis 9, 290–295.
48. Gallo, L.A., Denton, K.M., Moritz, K.M., Tare, M., Parkington, H.C., Davies, M., Tran, M., Jefferies, A.J. & Wlodek, M.E. 2012a. Long-term alteration in maternal blood pressure and renal function after pregnancy in normal and growth-restricted rats. Hypertension 60, 206–213.
49. Gallo, L.A., Tran, M., Moritz, K.M., Jefferies, A.J. & Wlodek, M.E. 2012b. Pregnancy in aged rats that were born small: cardiorenal and metabolic adaptations and second-generation fetal growth. FASEB J 26, 4337–4347.
50. Gallo, L.A., Tran, M., Moritz, K.M., Mazzuca, M.Q., Parry, L.J., Westcott, K.T., Jefferies, A.J., Cullen-McEwen, L.A. & Wlodek, M.E. 2012c. Cardio-renal and metabolic adaptations during pregnancy in female rats born small: implications for maternal health and second generation fetal growth. J Physiol 590, 617–630.
51. Gallo, L.A., Tran, M., Cullen-McEwen, L.A., Denton, K.M., Jefferies, A.J., Moritz, K.M. & Wlodek, M.E. 2014. Transgenerational programming of fetal nephron deficits and sex-specific adult hypertension in rats. Reprod Fertil Dev 26, 1032–1043.
52. Giannubilo, S.R., Dell'Uomo, B. & Tranquilli, A.L. 2006. Perinatal outcomes, blood pressure patterns and risk assessment of superimposed preeclampsia in mild chronic hypertensive pregnancy. Eur J Obstet Gynecol Reprod Biol 126, 63–67.
53. Gil, F.Z., Lucas, S.R., Gomes, G.N., Cavanal Mde, F. & Coimbra, T.M. 2005. Effects of intrauterine food restriction and long-term dietary supplementation with L-arginine on age-related changes in renal function and structure of rats. Pediatr Res 57, 724–731.
54. Gillis, E.E., Williams, J.M., Garrett, M.R., Mooney, J.N. & Sasser, J.M. 2015. The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia. Am J Physiol Regulat Integrat Comparat Physiol 309, R62–R70.
55. Goodfellow, J., Bellamy, M.F., Gorman, S.T., Brownlee, M., Ramsey, M.W., Lewis, M.J., Davies, D.P. & Henderson, A.H. 1998. Endothelial function is impaired in fit young adults of low birth weight. Cardiovasc Res 40, 600–606.
56. van der Graaf, A.M., Toering, T.J., Faas, M.M. & Lely, A.T. 2012. From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system?. Nephrol Dialysis Transplant 27(Suppl 3), iii51–iii57.
57. Hadar, E., Ashwal, E. & Hod, M. 2015. The preconceptional period as an opportunity for prediction and prevention of noncommunicable disease. Best Pract Res Clin Obst Gynaecol 29, 54–62.
58. Hamad, R.R., Eriksson, M.J., Silveira, A., Hamsten, A. & Bremme, K. 2007. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens 25, 2301–2307.
59. Heida, K.Y., Franx, A., van Rijn, B.B., Eijkemans, M.J., Boer, J.M., Verschuren, M.W., Oudijk, M.A., Bots, M.L. & van der Schouw, Y.T. 2015. Earlier Age of Onset of Chronic Hypertension and Type 2 Diabetes Mellitus After a Hypertensive Disorder of Pregnancy or Gestational Diabetes Mellitus. Hypertension 66, 1116–1122.
60. Henderson, J.T., Whitlock, E.P., O'Conner, E., Senger, C.A., Thompson, J.H. & Rowland, M.G. 2014, Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force, Rockville (MD): Agency for Healthcare Research and Quality (US), vol. Report no.: 14-05207-EF-1.
61. Hinchliffe, S.A., Lynch, M.R., Sargent, P.H., Howard, C.V. & Van Velzen, D. 1992. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 99, 296–301.
62. Hladunewich, M.A., Kingdom, J., Odutayo, A., Burns, K., Lai, V., O'Brien, T., Gandhi, S., Zimpelmann, J., Kiss, A., Miller, J. & Cherney, D. 2011. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab 96, 3517–3524.
63. Holley, J.L. & Schmidt, R.J. 2013. Changes in fertility and hormone replacement therapy in kidney disease. Adv Chronic Kidney Dis 20, 240–245.
64. Holwerda, K.M., Karumanchi, S.A. & Lely, A.T. 2015. Hydrogen sulfide: role in vascular physiology and pathology. Curr Opin Nephrol Hypertens 24, 170–176.
65. Hoy, W.E., Bertram, J.F., Denton, R.D., Zimanyi, M., Samuel, T. & Hughson, M.D. 2008. Nephron number, glomerular volume, renal disease and hypertension. Curr Opin Nephrol Hypertens 17, 258–265.
66. Hughson, M., Farris, A.B. 3rd, Douglas-Denton, R., Hoy, W.E. & Bertram, J.F. 2003. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 63, 2113–2122.
67. Hughson, M.D., Douglas-Denton, R., Bertram, J.F. & Hoy, W.E. 2006. Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int 69, 671–678.
68. Huppertz, B. 2008. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51, 970–975.
69. IJzerman, R.G., Stehouwer, C.D., de Geus, E.J., van Weissenbruch, M.M., Delemarre-van de Waal, H.A. & Boomsma, D.I. 2003. Low birth weight is associated with increased sympathetic activity: dependence on genetic factors. Circulation, 108, 566–571.
70. Innes, K.E., Byers, T.E., Marshall, J.A., Baron, A., Orleans, M. & Hamman, R.F. 2002. Association of a woman's own birth weight with subsequent risk for gestational diabetes. JAMA 287, 2534–2541.
71. Intapad, S., Tull, F.L., Brown, A.D., Dasinger, J.H., Ojeda, N.B., Fahling, J.M. & Alexander, B.T. 2013. Renal denervation abolishes the age-dependent increase in blood pressure in female intrauterine growth-restricted rats at 12 months of age. Hypertension 61, 828–834.
72. Jayet, P.Y., Rimoldi, S.F., Stuber, T., Salmon, C.S., Hutter, D., Rexhaj, E., Thalmann, S., Schwab, M., Turini, P., Sartori-Cucchia, C., Nicod, P., Villena, M., Allemann, Y., Scherrer, U. & Sartori, C. 2010. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 122, 488–494.
73. Johal, T., Lees, C.C., Everett, T.R. & Wilkinson, I.B. 2014. The nitric oxide pathway and possible therapeutic options in pre-eclampsia. Br J Clin Pharmacol 78, 244–257.
74. de Jong, F., Monuteaux, M.C., van Elburg, R.M., Gillman, M.W. & Belfort, M.B. 2012. Systematic review and meta-analysis of preterm birth and later systolic blood pressure. Hypertension 59, 226–234.
75. Kajantie, E., Eriksson, J.G., Osmond, C., Thornburg, K. & Barker, D.J. 2009. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke J Cerebr Circulat 40, 1176–1180.
76. Keller, G., Zimmer, G., Mall, G., Ritz, E. & Amann, K. 2003. Nephron number in patients with primary hypertension. New Engl J Med 348, 101–108.
77. Kermack, A.J., Van Rijn, B.B., Houghton, F.D., Calder, P.C., Cameron, I.T. & Macklon, N.S. 2015. The ‘Developmental Origins’ Hypothesis: relevance to the obstetrician and gynecologist. J Dev Origins Health Dis 6, 415–424.
78. King, T.F., Bergin, D.A., Kent, E.M., Manning, F., Reeves, E.P., Dicker, P., McElvaney, N.G., Sreenan, S., Malone, F.D. & McDermott, J.H. 2013. Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk? J Clin Endocrinol Metab 98, E33–E39.
79. Koeners, M.P., van Faassen, E.E., Wesseling, S., de Sain-van der Velden, M., Koomans, H.A., Braam, B. & Joles, J.A. 2007. Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 50, 1077–1084.
80. Koeners, M.P., Braam, B., van der Giezen, D.M., Goldschmeding, R. & Joles, J.A. 2008. A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats. Am J Physiol Regulat Integrat Comparat Physiol 294, R1847–R1855.
81. Koeners, M.P., Braam, B., van der Giezen, D.M., Goldschmeding, R. & Joles, J.A. 2010. Perinatal micronutrient supplements ameliorate hypertension and proteinuria in adult fawn-hooded hypertensive rats. Am J Hypertens 23, 802–808.
82. Koeners, M.P., Braam, B. & Joles, J.A. 2011a. Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats. J Hypertens 29, 1160–1166.
83. Koeners, M.P., Wesseling, S., Ulu, A., Sepulveda, R.L., Morisseau, C., Braam, B., Hammock, B.D. & Joles, J.A. 2011b. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 300, E691–E698.
84. Koeners, M.P., Wesseling, S., Sanchez, M., Braam, B. & Joles, J.A. 2016. Perinatal inhibition of NF-KappaB has long-term antihypertensive and renoprotective effects in fawn-hooded hypertensive rats. Am J Hypertens 29, 123–131.
85. Koshy, T.S., Sara, V.R., King, T.L. & Lazarus, L. 1975. The influence of protein restriction imposed at various stages of pregnancy on fetal and placental development. Growth 39, 497–506.
86. Krause, B.J., Costello, P.M., Munoz-Urrutia, E., Lillycrop, K.A., Hanson, M.A. & Casanello, P. 2013. Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses. Epigenetics 8, 944–952.
87. Law, C.M. & Shiell, A.W. 1996. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 14, 935–941.
88. Lawlor, D.A., Davey Smith, G. & Ebrahim, S. 2002. Birth weight of offspring and insulin resistance in late adulthood: cross sectional survey. BMJ 325, 359.
89. Lewandowski, A.J., Davis, E.F., Yu, G., Digby, J.E., Boardman, H., Whitworth, P., Singhal, A., Lucas, A., McCormick, K., Shore, A.C. & Leeson, P. 2015. Elevated blood pressure in preterm-born offspring associates with a distinct antiangiogenic state and microvascular abnormalities in adult life. Hypertension 65, 607–614.
90. Lu, F., Bytautiene, E., Tamayo, E., Gamble, P., Anderson, G.D., Hankins, G.D., Longo, M. & Saade, G.R. 2007a. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol, 197, 418.e1–418.e5.
91. Lu, F., Longo, M., Tamayo, E., Maner, W., Al-Hendy, A., Anderson, G.D., Hankins, G.D. & Saade, G.R. 2007b. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 196, 396.e1-7; discussion 396.e7.
92. Luyckx, V.A. & Brenner, B.M. 2015. Birth weight, malnutrition and kidney-associated outcomes–a global concern. Nat Rev Nephrol 11, 135–149.
93. Luyckx, V.A., Bertram, J.F., Brenner, B.M., Fall, C., Hoy, W.E., Ozanne, S.E. & Vikse, B.E. 2013. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382, 273–283.
94. Lykke, J.A., Paidas, M.J., Triche, E.W. & Langhoff-Roos, J. 2012. Fetal growth and later maternal death, cardiovascular disease and diabetes. Acta Obstet Gynecol Scand 91, 503–510.
95. Magnussen, E.B., Vatten, L.J., Smith, G.D. & Romundstad, P.R. 2009. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 114, 961–970.
96. Manalich, R., Reyes, L., Herrera, M., Melendi, C. & Fundora, I. 2000. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int 58, 770–773.
97. Mangos, G.J., Spaan, J.J., Pirabhahar, S. & Brown, M.A. 2012. Markers of cardiovascular disease risk after hypertension in pregnancy. J Hypertens 30, 351–358.
98. Manning, J., Beutler, K., Knepper, M.A. & Vehaskari, V.M. 2002. Upregulation of renal BSC1 and TSC in prenatally programmed hypertension. Am J Physiol Renal Physiol 283, F202–F206.
99. Martillotti, G., Ditisheim, A., Burnier, M., Wagner, G., Boulvain, M., Irion, O. & Pechere-Bertschi, A. 2013. Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia. Hypertension 62, 802–808.
100. Master, J.S., Zimanyi, M.A., Yin, K.V., Moritz, K.M., Gallo, L.A., Tran, M., Wlodek, M.E. & Black, M.J. 2014. Transgenerational left ventricular hypertrophy and hypertension in offspring after uteroplacental insufficiency in male rats. Clin Exp Pharmacol Physiol 41, 884–890.
101. Mazzuca, M.Q., Wlodek, M.E., Dragomir, N.M., Parkington, H.C. & Tare, M. 2010. Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. J Physiol 588, 1997–2010.
102. McDonald, S.D., Malinowski, A., Zhou, Q., Yusuf, S. & Devereaux, P.J. 2008. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 156, 918–930.
103. McDonald, S.D., Han, Z., Walsh, M.W., Gerstein, H.C. & Devereaux, P.J. 2010. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 55, 1026–1039.
104. Morton, J.S., Rueda-Clausen, C.F. & Davidge, S.T. 2011. Flow-mediated vasodilation is impaired in adult rat offspring exposed to prenatal hypoxia. J Appl Physiol 110, 1073–1082.
105. Mosca, L., Benjamin, E.J., Berra, K., Bezanson, J.L., Dolor, R.J., Lloyd-Jones, D.M., Newby, L.K., Pina, I.L., Roger, V.L., Shaw, L.J. et al. 2011. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 57, 1404–1423.
106. Mueller, C.A., Eme, J., Burggren, W.W., Roghair, R.D. & Rundle, S.D. 2015. Challenges and opportunities in developmental integrative physiology. Comp Biochem Physiol A Mol Integr Physiol 184, 113–124.
107. Murano, Y., Nishizaki, N., Endo, A., Ikeda, N., Someya, T., Nakagawa, M., Hara, T., Sakuraya, K., Hara, S., Hirano, D., Suzuki, M., Shoji, H., Fujinaga, S., Ohtomo, Y. & Shimizu, T. 2015. Evaluation of kidney dysfunction and angiotensinogen as an early novel biomarker of intrauterine growth restricted offspring rats. Pediatr Res, 78, 678–682.
108. Nanduri, J., Makarenko, V., Reddy, V.D., Yuan, G., Pawar, A., Wang, N., Khan, S.A., Zhang, X., Kinsman, B., Peng, Y.J., Kumar, G.K., Fox, A.P., Godley, L.A., Semenza, G.L. & Prabhakar, N.R. 2012. Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis. Proc Natl Acad Sci USA 109, 2515–2520.
109. Nevis, I.F., Reitsma, A., Dominic, A., McDonald, S., Thabane, L., Akl, E.A., Hladunewich, M., Akbari, A., Joseph, G., Sia, W., Iansavichus, A.V. & Garg, A.X. 2011. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol 6, 2587–2598.
110. Ngo, A.D., Roberts, C.L., Chen, J.S. & Figtree, G. 2015. Delivery of a small-for-gestational-age infant and risk of maternal cardiovascular disease–a population-based record linkage study. Heart Lung Circ 24, 696–704.
111. Nilsson, P.M., Li, X., Sundquist, J. & Sundquist, K. 2009. Maternal cardiovascular disease risk in relation to the number of offspring born small for gestational age: national, multi-generational study of 2.7 million births. Acta Paediatr 98, 985–989.
112. Noris, M., Perico, N. & Remuzzi, G. 2005. Mechanisms of disease: pre-eclampsia. Nature clinical practice. Nephrology 1, 98–114; quiz 120.
113. Oglaend, B., Forman, M.R., Romundstad, P.R., Nilsen, S.T. & Vatten, L.J. 2009. Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies. J Hypertens 27, 2051–2054.
114. Ojeda, N.B. 2011. Low birth weight increases susceptibility to renal injury in a rat model of mild ischemia-reperfusion. Am J Physiol Renal Physiol 301, F420–F426.
115. Ojeda, N.B., Grigore, D., Yanes, L.L., Iliescu, R., Robertson, E.B., Zhang, H. & Alexander, B.T. 2007a. Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring. Am J Physiol Regulat Integrat Comparat Physiol 292, R758–R763.
116. Ojeda, N.B., Johnson, W.R., Dwyer, T.M. & Alexander, B.T. 2007b. Early renal denervation prevents development of hypertension in growth-restricted offspring. Clin Exp Pharmacol Physiol 34, 1212–1216.
117. Ojeda, N.B., Royals, T.P., Black, J.T., Dasinger, J.H., Johnson, J.M. & Alexander, B.T. 2010. Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring. Am J Physiol Regulat Integrat Comparat Physiol 298, R1421–R1427.
118. Ojeda, N.B., Royals, T.P. & Alexander, B.T. 2013. Sex differences in the enhanced responsiveness to acute angiotensin II in growth-restricted rats: role of fasudil, a Rho kinase inhibitor. Am J Physiol Renal Physiol 304, F900–F907.
119. Ojeda, N.B., Intapad, S. & Alexander, B.T. 2014. Sex differences in the developmental programming of hypertension. Acta Physiol, 210, 307–316.
120. Paauw, N.D., Luijken, K., Franx, A., Verhaar, M.C. & Lely, A.T. 2016. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin Sci 130, 239–246.
121. Paez, O., Alfie, J., Gorosito, M., Puleio, P., de Maria, M., Prieto, N. & Majul, C. 2009. Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of pre-eclampsia. Clin Exp Hypertens 31, 544–552.
122. Palti, H. & Rothschild, E. 1989. Blood pressure and growth at 6 years of age among offsprings of mothers with hypertension of pregnancy. Early Human Dev 19, 263–269.
123. Payne, J.A., Alexander, B.T. & Khalil, R.A. 2003. Reduced endothelial vascular relaxation in growth-restricted offspring of pregnant rats with reduced uterine perfusion. Hypertension 42, 768–774.
124. Payne, J.A., Alexander, B.T. & Khalil, R.A. 2004. Decreased endothelium-dependent NO-cGMP vascular relaxation and hypertension in growth-restricted rats on a high-salt diet. Hypertension 43, 420–427.
125. Prior, L.J., Davern, P.J., Burke, S.L., Lim, K., Armitage, J.A. & Head, G.A. 2014. Exposure to a high-fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 63, 338–345.
126. Pruthi, D., Khankin, E.V., Blanton, R.M., Aronovitz, M., Burke, S.D., McCurley, A., Karumanchi, S.A. & Jaffe, I.Z. 2015. Exposure to experimental preeclampsia in mice enhances the vascular response to future injury. Hypertension 65, 863–870.
127. Racasan, S., Braam, B., van der Giezen, D.M., Goldschmeding, R., Boer, P., Koomans, H.A. & Joles, J.A. 2004. Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 44, 83–88.
128. Racasan, S., Braam, B., Koomans, H.A. & Joles, J.A. 2005. Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol 288, F626–F636.
129. Rasmussen, L.G., Lykke, J.A. & Staff, A.C. 2015. Angiogenic biomarkers in pregnancy: defining maternal and fetal health. Acta Obstet Gynecol Scand 94, 820–832.
130. Ray, J.G., Vermeulen, M.J., Schull, M.J. & Redelmeier, D.A. 2005. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366, 1797–1803.
131. Redman, C.W. & Sargent, I.L. 2010. Immunology of pre-eclampsia. Am J Reprod Immunol 63, 534–543.
132. Refuerzo, J.S., Sokol, R.J., Aranda, J.V., Hallak, M., Hotra, J.W., Kruger, M. & Sorokin, Y. 2006. Sildenafil citrate and fetal outcome in pregnant rats. Fetal Diagn Ther 21, 259–263.
133. Rexhaj, E., Bloch, J., Jayet, P.Y., Rimoldi, S.F., Dessen, P., Mathieu, C., Tolsa, J.F., Nicod, P., Scherrer, U. & Sartori, C. 2011. Fetal programming of pulmonary vascular dysfunction in mice: role of epigenetic mechanisms. Am J Physiol Heart Circulat Physiol 301, H247–H252.
134. Rexhaj, E., Pireva, A., Paoloni-Giacobino, A., Allemann, Y., Cerny, D., Dessen, P., Sartori, C., Scherrer, U. & Rimoldi, S.F. 2015. Prevention of vascular dysfunction and arterial hypertension in mice generated by assisted reproductive technologies by addition of melatonin to culture media. Am J Physiol Heart Circulat Physiol 309, H1151–H1156.
135. Rey, E. & Couturier, A. 1994. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 171, 410–416.
136. Richter, V.F., Briffa, J.F., Moritz, K.M., Wlodek, M.E. & Hryciw, D.H. 2016. The role of maternal nutrition, metabolic function and the placenta in developmental programming of renal dysfunction. Clin Exp Pharmacol Physiol, 43, 135–141.
137. van Rijn, B.B., Nijdam, M.E., Bruinse, H.W., Roest, M., Uiterwaal, C.S., Grobbee, D.E., Bots, M.L. & Franx, A. 2013. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol 121, 1040–1048.
138. Rogvi, R., Forman, J.L., Damm, P. & Greisen, G. 2012. Women born preterm or with inappropriate weight for gestational age are at risk of subsequent gestational diabetes and pre-eclampsia. PLoS One 7, e34001.
139. Romundstad, P.R., Magnussen, E.B., Smith, G.D. & Vatten, L.J. 2010. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation 122, 579–584.
140. Rueda-Clausen, C.F., Morton, J.S., Lopaschuk, G.D. & Davidge, S.T. 2011. Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion. Cardiovasc Res 90, 285–294.
141. Rueda-Clausen, C.F., Morton, J.S., Dolinsky, V.W., Dyck, J.R. & Davidge, S.T. 2012. Synergistic effects of prenatal hypoxia and postnatal high-fat diet in the development of cardiovascular pathology in young rats. Am J Physiol Regulat Integrat Comparat Physiol 303, R418–R426.
142. Samuelsson, A.M. 2014. New perspectives on the origin of hypertension; the role of the hypothalamic melanocortin system. Exp Physiol 99, 1110–1115.
143. Sanders, M.W., Fazzi, G.E., Janssen, G.M., Blanco, C.E. & De Mey, J.G. 2005. High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats. Hypertension 46, 71–75.
144. Sandvik, M.K., Hallan, S., Svarstad, E. & Vikse, B.E. 2013. Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol 8, 1126–1134.
145. Santos, M.S. & Joles, J.A. 2012. Early determinants of cardiovascular disease. Best Pract Res Clin Endocrinol Metab 26, 581–597.
146. Sattar, N. & Greer, I.A. 2002. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325, 157–160.
147. Saxena, A.R., Karumanchi, S.A., Brown, N.J., Royle, C.M., McElrath, T.F. & Seely, E.W. 2010. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 55, 1239–1245.
148. Schobel, H.P., Fischer, T., Heuszer, K., Geiger, H. & Schmieder, R.E. 1996. Preeclampsia – a state of sympathetic overactivity. New Engl J Med 335, 1480–1485.
149. Seghieri, G., Anichini, R., De Bellis, A., Alviggi, L., Franconi, F. & Breschi, M.C. 2002. Relationship between gestational diabetes mellitus and low maternal birth weight. Diabetes Care 25, 1761–1765.
150. Seidman, D.S., Laor, A., Gale, R., Stevenson, D.K., Mashiach, S. & Danon, Y.L. 1991. Pre-eclampsia and offspring's blood pressure, cognitive ability and physical development at 17-years-of-age. Br J Obstet Gynaecol 98, 1009–1014.
151. Shah, D.A. & Khalil, R.A. 2015. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol 95, 211–226.
152. Shankaran, S., Das, A., Bauer, C.R., Bada, H., Lester, B., Wright, L., Higgins, R. & Poole, K. 2006. Fetal origin of childhood disease: intrauterine growth restriction in term infants and risk for hypertension at 6 years of age. Arch Pediatr Adolesc Med 160, 977–981.
153. Sibai, B.M. 2002. Chronic hypertension in pregnancy. Obstet Gynecol 100, 369–377.
154. Spaanderman, M.E., Ekhart, T.H., de Leeuw, P.W. & Peeters, L.L. 2004. Angiotensin II sensitivity in nonpregnant formerly preeclamptic women and healthy parous controls. J Soc Gynecol Investig 11, 416–422.
155. Stelloh, C., Allen, K.P., Mattson, D.L., Lerch-Gaggl, A., Reddy, S. & El-Meanawy, A. 2012. Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Translat Res 159, 80–89.
156. Suzuki, H., Watanabe, Y., Arima, H., Kobayashi, K., Ohno, Y. & Kanno, Y. 2008. Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol 12, 102–109.
157. Svenningsen, P., Andersen, H., Nielsen, L.H. & Jensen, B.L. 2015. Urinary serine proteases and activation of ENaC in kidney–implications for physiological renal salt handling and hypertensive disorders with albuminuria. Pflugers Archiv 467, 531–542.
158. Tain, Y.L. & Joles, J.A. 2015. Reprogramming: a Preventive Strategy in Hypertension Focusing on the Kidney. Int J Mol Sci 17, pii: E23. doi:10.3390/ijms17010023.
159. Tain, Y.L., Huang, L.T. & Chan, J.Y. 2014a. Transcriptional regulation of programmed hypertension by melatonin: an epigenetic perspective. Int J Mol Sci 15, 18484–18495.
160. Tain, Y.L., Lee, C.T. & Huang, L.T. 2014b. Long-term effects of maternal citrulline supplementation on renal transcriptome prevention of nitric oxide depletion-related programmed hypertension: the impact of gene-nutrient interactions. Int J Mol Sci 15, 23255–23268.
161. Taylor, P.D., Samuelsson, A.M. & Poston, L. 2014. Maternal obesity and the developmental programming of hypertension: a role for leptin. Acta Physiol 210, 508–523.
162. Tenhola, S., Rahiala, E., Halonen, P., Vanninen, E. & Voutilainen, R. 2006. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res 59, 320–324.
163. Toering, T.J., van der Graaf, A.M., Visser, F.W., Groen, H., Faas, M.M., Navis, G. & Lely, A.T. 2015. Higher filtration fraction in formerly early-onset preeclamptic women without comorbidity. Am J Physiol Renal Physiol 308, F824–F831.
164. Tranquilli, A.L., Dekker, G., Magee, L., Roberts, J., Sibai, B.M., Steyn, W., Zeeman, G.G. & Brown, M.A. 2014. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregn Hypertens 4, 97–104.
165. Van der Graaf, A.M., Toering, T., Van der Wiel, M.K., Navis, G., Buikema, H., Lely, A.T. & Faas, M.M. 2014. Angiotensin II Sensitivity after Preeclampsia in Human and Rat
166. Venditti, C.C., Casselman, R., Young, I., Karumanchi, S.A. & Smith, G.N. 2014. Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model. PLoS One 9, e106502.
167. Vernay, M., Aidara, M., Salanave, B., Deschamps, V., Malon, A., Oleko, A., Mallion, J.M., Hercberg, S. & Castetbon, K. 2012. Diet and blood pressure in 18-74-year-old adults: the French Nutrition and Health Survey (ENNS, 2006-2007). J Hypertens 30, 1920–1927.
168. Vikse, B.E., Irgens, L.M., Leivestad, T., Skjaerven, R. & Iversen, B.M. 2008. Preeclampsia and the risk of end-stage renal disease. New Engl J Med 359, 800–809.
169. Vikse, B.E., Irgens, L.M., Karumanchi, S.A., Thadhani, R., Reisaeter, A.V. & Skjaerven, R. 2012. Familial factors in the association between preeclampsia and later ESRD. Clin J Am Soc Nephrol 7, 1819–1826.
170. Villanueva-Garcia, D., Mota-Rojas, D., Hernandez-Gonzalez, R., Sanchez-Aparicio, P., Alonso-Spilsbury, M., Trujillo-Ortega, M.E., Necoechea, R.R. & Nava-Ocampo, A.A. 2007. A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. J Obst Gynaecol 27, 255–259.
171. Walton, S.L., Singh, R.R., Tan, T., Paravicini, T.M. & Moritz, K.M. 2016. Late gestational hypoxia and a postnatal high salt diet programs endothelial dysfunction and arterial stiffness in adult mouse offspring. J Physiol 594, 1451–1463.
172. Wang, I.K., Muo, C.H., Chang, Y.C., Liang, C.C., Chang, C.T., Lin, S.Y., Yen, T.H., Chuang, F.R., Chen, P.C., Huang, C.C., Wen, C.P., Sung, F.C. & Morisky, D.E. 2013. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ 185, 207–213.
173. White, W.M., Garrett, A.T., Craici, I.M., Wagner, S.J., Fitz-Gibbon, P.D., Butters, K.A., Brost, B.C., Rose, C.H., Grande, J.P. & Garovic, V.D. 2014. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS One 9, e92693.
174. Williams, D. & Davison, J. 2008. Chronic kidney disease in pregnancy. BMJ 336, 211–215.
175. Williams, C.L., Hayman, L.L., Daniels, S.R., Robinson, T.N., Steinberger, J., Paridon, S. & Bazzarre, T. 2002. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106, 143–160.
176. Wlodek, M.E., Westcott, K., Siebel, A.L., Owens, J.A. & Moritz, K.M. 2008. Growth restriction before or after birth reduces nephron number and increases blood pressure in male rats. Kidney Int 74, 187–195.
177. Wolf, M., Hubel, C.A., Lam, C., Sampson, M., Ecker, J.L., Ness, R.B., Rajakumar, A., Daftary, A., Shakir, A.S., Seely, E.W., Roberts, J.M., Sukhatme, V.P., Karumanchi, S.A. & Thadhani, R. 2004. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 89, 6239–6243.
178. Woods, L.L., Ingelfinger, J.R., Nyengaard, J.R. & Rasch, R. 2001. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49, 460–467.
179. Woods, L.L., Weeks, D.A. & Rasch, R. 2004. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int 65, 1339–1348.
180. Woods, L.L., Ingelfinger, J.R. & Rasch, R. 2005. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regulat Integrat Comparat Physiol 289, R1131–R1136.
181. Wu, C.C., Chen, S.H., Ho, C.H., Liang, F.W., Chu, C.C., Wang, H.Y. & Lu, Y.H. 2014a. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol 210, 147e1–147e8.
182. Wu, T.H., Kuo, H.C., Lin, I.C., Chien, S.J., Huang, L.T. & Tain, Y.L. 2014b. Melatonin prevents neonatal dexamethasone induced programmed hypertension: histone deacetylase inhibition. J Steroid Biochem Molecul Biol 144, 253–259.
183. Wu, Z., Siuda, D., Xia, N., Reifenberg, G., Daiber, A., Munzel, T., Forstermann, U. & Li, H. 2015. Maternal treatment of spontaneously hypertensive rats with pentaerythritol tetranitrate reduces blood pressure in female offspring. Hypertension 65, 232–237.
184. Yinon, Y., Kingdom, J.C., Odutayo, A., Moineddin, R., Drewlo, S., Lai, V., Cherney, D.Z. & Hladunewich, M.A. 2010. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation 122, 1846–1853.
185. Zanardo, V., Visentin, S., Trevisanuto, D., Bertin, M., Cavallin, F. & Cosmi, E. 2013. Fetal aortic wall thickness: a marker of hypertension in IUGR children? Hypertens Res 36, 440–443.
186. Zetterstrom, K., Lindeberg, S., Haglund, B., Magnuson, A. & Hanson, U. 2007. Being born small for gestational age increases the risk of severe pre-eclampsia. BJOG 114, 319–324.
187. Zhou, Y., Niu, J., Duan, D., Lei, Q., Wen, J., Lin, X., Lv, L. & Chen, L. 2015. Lipoprotein-associated phospholipase A2 is associated with postpartum hypertension in women with history of preeclampsia. Heart Vessels 30, 503–509.